On November 16, 2023, the board of directors of Applied Therapeutics, Inc. appointed Les Funtleyder as chief financial officer and principal financial officer of the company, effective as of November 20, 2023 (the Start Date).
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.42 USD | +0.45% | -5.52% | +30.30% |
May. 09 | Applied Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | Earnings Flash (APLT) APPLIED THERAPEUTICS Posts Q1 Revenue $190,000 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.30% | 503M | |
+7.81% | 113B | |
+10.90% | 106B | |
+0.41% | 22.27B | |
-11.89% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.63% | 17.24B | |
+6.76% | 14.29B | |
+35.78% | 12.52B |
- Stock Market
- Equities
- APLT Stock
- News Applied Therapeutics, Inc.
- Applied Therapeutics, Inc. Appoints Les Funtleyder as Chief Financial Officer, Effective November 20, 2023